Ordinary Rebalance | Solactive BBVA Health & Wellness SIC MXN Index | Effective Date 12th June 2024
In the ordinary rebalance, the following composition will be implemented effective open 12.06.2024:
ADIDAS AG |
AGILENT TECHNOLOGIES INC |
ALCON INC |
ALIGN TECHNOLOGY INC |
ASTRAZENECA PLC |
BECTON DICKINSON AND CO |
BEIERSDORF AG |
CENTENE CORP |
COLOPLAST AS CLASS B |
CONVATEC GROUP PLC |
COOPER COMPANIES INC |
CSL LTD ORD |
DANAHER CORP |
DEMANT A/S |
EISAI |
ELEVANCE HEALTH INC |
GENMAB A/S |
GILEAD SCIENCES INC |
GSK PLC |
HCA HEALTHCARE INC |
HUMANA INC |
ICON PLC |
ILLUMINA INC |
INCYTE CORP |
IQVIA HOLDINGS INC |
L OREAL SA |
LONZA GROUP AG |
MERCK & CO. INC. |
NIKE INC |
NOVO NORDISK A/S |
PROCTER & GAMBLE CO |
REGENERON PHARMACEUTICALS |
RESMED INC |
ROYALTY PHARMA PLC- CL A |
SANTEN PHARMACEUTICAL CO LTD ORD |
SARTORIUS STEDIM BIOTECH SA |
STERIS PLC |
STEVANATO GROUP SPA |
STRAUMANN HOLDING AG |
STRYKER CORP |
SWEDISH ORPHAN BIOVITRUM AB |
TERUMO CORP |
THE CIGNA GROUP |
THERMO FISHER SCIENTIFIC INC |
UCB SA |
ULTA BEAUTY INC |
UNITEDHEALTH GROUP INC |
VEEVA SYSTEMS INC |
VERTEX PHARMACEUTICALS INC |
ZIMMER BIOMET HOLDINGS INC |